BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 472125)

  • 21. [Radiobiological characteristics of a medical proton beam of 1000 MeV energy].
    Konnov BA; Komarov EI; Kozhina TN; Nizkovolos VB; Karlin DL
    Med Radiol (Mosk); 1977 Jul; 22(7):33-40. PubMed ID: 909365
    [No Abstract]   [Full Text] [Related]  

  • 22. The radiobiological and physical basis for radiotherapy with protons and heavier ions.
    Kraft G
    Strahlenther Onkol; 1990 Jan; 166(1):10-3. PubMed ID: 2154042
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dosimetry of clinical neutron and proton beams: an overview of recommendations.
    Vynckier S; ;
    Radiat Prot Dosimetry; 2004; 110(1-4):565-72. PubMed ID: 15353710
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A measuring system with a recombination chamber for neutron dosimetry around medical accelerators.
    Golnik N; Kamiński P; Zielczyński M
    Radiat Prot Dosimetry; 2004; 110(1-4):273-6. PubMed ID: 15353658
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Partial tolerance and time dose fractionation values for common external beam radiation therapy schedules.
    Hibbitts KR; Miller MP; Raeside DE; Bogardus CR
    Radiol Technol; 1981; 52(5):533-42. PubMed ID: 6801724
    [No Abstract]   [Full Text] [Related]  

  • 26. A review of the impact of photon and proton external beam radiotherapy treatment modalities on the dose distribution in field and out-of-field; implications for the long-term morbidity of cancer survivors.
    Palm A; Johansson KA
    Acta Oncol; 2007; 46(4):462-73. PubMed ID: 17497313
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Shielding design for a laser-accelerated proton therapy system.
    Fan J; Luo W; Fourkal E; Lin T; Li J; Veltchev I; Ma CM
    Phys Med Biol; 2007 Jul; 52(13):3913-30. PubMed ID: 17664585
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dosimetric impact of tantalum markers used in the treatment of uveal melanoma with proton beam therapy.
    Newhauser WD; Koch NC; Fontenot JD; Rosenthal SJ; S Gombos D; Fitzek MM; Mohan R
    Phys Med Biol; 2007 Jul; 52(13):3979-90. PubMed ID: 17664589
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Particle radiotherapy.
    Griffin TW
    Hosp Pract (Off Ed); 1985 Sep; 20(9):91-5, 98-106. PubMed ID: 2993322
    [No Abstract]   [Full Text] [Related]  

  • 30. An overview of recent charged-particle radiation biology in Italy.
    Belli M
    Phys Med; 2001; 17 Suppl 1():278-82. PubMed ID: 11780619
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proton therapy in Japan.
    Tsunemoto H; Morita S; Ishikawa T; Furukawa S; Kawachi K; Kanai T; Ohara H; Kitagawa T; Inada T
    Radiat Res Suppl; 1985; 8():S235-43. PubMed ID: 3003785
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute skin reactions observed in fractionated proton irradiation.
    Arimoto T; Maruhashi N; Takada Y; Hayakawa Y; Inada T; Kitagawa T
    Radiat Med; 1989; 7(1):23-7. PubMed ID: 2548232
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No.
    Suit H; Kooy H; Trofimov A; Farr J; Munzenrider J; DeLaney T; Loeffler J; Clasie B; Safai S; Paganetti H
    Radiother Oncol; 2008 Feb; 86(2):148-53. PubMed ID: 18237800
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The relative biological effect of high-Z, high-LET charged particles for spermatogonial killing.
    Alpen EL; Powers-Risius P
    Radiat Res; 1981 Oct; 88(1):132-43. PubMed ID: 7302123
    [No Abstract]   [Full Text] [Related]  

  • 35. Heavy charged particle radiotherapy.
    Chen GT; Castro JR; Quivey JM
    Annu Rev Biophys Bioeng; 1981; 10():499-529. PubMed ID: 7020583
    [No Abstract]   [Full Text] [Related]  

  • 36. [A device for the depth-dose distribution measurement of a medical proton beam in radiotherapy].
    Agapov AV; Mitsyn GV; Shvidkiĭ ; Shipulin KN
    Med Tekh; 2013; (5):28-31. PubMed ID: 24364168
    [No Abstract]   [Full Text] [Related]  

  • 37. Accelerators for heavy-charged-particle radiation therapy.
    Coutrakon GB
    Technol Cancer Res Treat; 2007 Aug; 6(4 Suppl):49-54. PubMed ID: 17668952
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Studies of absorbed dose determinations and spatial dose distributions for high energy proton beams (author's transl)].
    Hiraoka T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1982 Jan; 42(1):41-65. PubMed ID: 6285273
    [No Abstract]   [Full Text] [Related]  

  • 39. Biophysical studies with spatially correlated ions. 2. Multiple scattering, experimental facility, and dosimetry.
    Colvett RD; Rohrig N
    Radiat Res; 1979 May; 78(2):192-209. PubMed ID: 451151
    [No Abstract]   [Full Text] [Related]  

  • 40. Potential for low-LET charged-particle radiation therapy in cancer.
    Goitein M; Suit HD; Gragoudas E; Koehler AM; Wilson R
    Radiat Res Suppl; 1985; 8():S297-309. PubMed ID: 3937175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.